Early response measurement in non small cell lung cancer.
Completed
- Conditions
- lung cancer1003866610029107non-small cell lung cancer
- Registration Number
- NL-OMON31456
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
stage III with cytologically or histologically proven N2 or N3 disease or T4 patients who are to be treated with concomitant chemoradiotherapy
age 18-70
performance status ECOG 0-1
no contraindications for chemo-radiotherapy, surgery or diagnostic procedures
Exclusion Criteria
pregnancy
previous radiotherapy to the chest
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Early response assesment during treatment with concomitant chemo-radiotherapy<br /><br>for stage III lung cancer with FDG-PET-CT imaging and biological tumor<br /><br>characteristics.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Survival, progression-free survival, toxicity.</p><br>